OPKO Health, Inc., 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 17,062 shares at $8.75 ($149K) on 2013-11-20, disclosed to the SEC on 2013-11-21.
Open-market sale of $149k SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.75 | 100 | $875 | 0.6% |
| 2 | $8.75 | 16,962 | $148K | 99.4% |
| Total | $8.75 avg | 17,062 | $149K | 100% |
| Filing → |
| WGS | SELL | 2024-08-08 | $3.9M | — | Filing → |
| WGS | SELL | 2024-08-02 | $6.0M | — | Filing → |
| WGS | SELL | 2024-07-31 | $1.7M | — | Filing → |